RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 5:01 PM
Followers: 439
Posts Today: 12
Views Today: 36214

CYDY Stock Quote & Tools

$0.2000 ▲ +0.0000 (+0.00%) As of Oct 12, 3:52 PM EDT
Last0.2000
$ Chg0.0000
Open0.1982
High0.2072
Beta1.4964
Year High0.397
Market Cap293.90M
P/B Ratio-2.68
EPS-0.03
Avg Vol (30d)1.59M
Volume1.17M
% Chg+0.00%
Prev Close0.2000
Low0.1970
VWAP0.19940
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. SeeWhyDY

    I believe we would have had FDA approval for HIV Combo 6months ago if we just submitted the

    (5)
  2. Kevin0461

    As far CEOs go... Id say NP is a VERY humble person. IMHO

    (7)
  3. Shopcop7

    I really wish Nader would be more willing to actually answer some questions in depth. Seemed like

    (7)
  4. Werner

    I am convinced that Vyrologix really works and the CC from yesterday was a good one...but, one

  5. SeeWhyDY

    Moderators please ensure People add source links if they cut and paste or copy quotes from other

    (1)
  6. chuckles759

    ... might have some issues with zero population growth if LL resolves the fertility problem af a

    (2)
  7. ohm20

    They say it is inflammation that ages us the most. Well, if that is true... we know the drug

    (2)
  8. ohm20

    but by then ...we become... what we are competing with..Big Pharma Then it

    (2)
  9. Goosebumps

    Vyrologix is the fountain of youth is what I read somewhere. I was told by someone recently that if

    (2)
  10. Cassandra X

    Yeah, I said billions of vials so I will try to lay down my thinking on this. Before today I was

    (9)
  11. ohm20

    But just think of how much leronlimab we'll sell when the dollar is equal to one Philippine peso.

    (1)
  12. ohm20

    "so if are biggest concern is OMG the shorts could take this down to $2.75 while we wait for

    (2)
  13. ohm20

    You are almost certainly correct but it was fun getting the HGEN crowd riled up while it lasted.

  14. ohm20

    Why cant we submit our CD-10 Trial analysis and our CD-12 up to 50% interim analysis that

    (2)
  15. Shelly2626

    Yep Makes good sense Lets go cydy

  16. CGC

    Could be way off base but I kept thinking of 'off label' use with an approval - in response to

    (2)
  17. grow

    I think you aren't accounting for the time that the enrolled patients need to be observed in order

  18. grow

    Thanks for your thoughts. I can appreciate that scenario. Thank goodness they seriously moved the

  19. Goosebumps

    Cytodyn web sites CNN article about the Philippines and the Executive Order 120 signed by the

    (2)
  20. CDiddy

    If the FDA is motivated enough to give us EUA after phase 2, they will be motivated enough to do it

  21. ohm20

    I would expect trial data should be ready to go to the FDA towards the end of January. We might get

  22. blafarm

    It was made abundantly clear in this CC that the need for Leronlimab could be in the

    (1)
  23. mtruong34

    Not understanding how you interpret my post as saying NP created the codes and put into the system.

  24. RTB

    I hope NP didn't confuse the 60 patient interim plan with 60%! (I realize it doesn't make a whole

    (4)
  25. blafarm

    Dr.SK mentioned during the call that it was fatigue.

  26. Borel Fields

    If that's what they did, it is wrong, but 402/257 not = 1.37. My impression was that the DSMC

  27. blafarm

    I think its worth reminding both of you that this is a phase 2 trial. One of the main

    (11)
  28. grow

    ohm20, what are your thoughts about when we will publicly hear efficacy data from CD12? Will we

  29. otcaddict

    So you are saying NP can create the code and put that in the system? I have a bunch of 420 going no

  30. CDiddy

    That's how I see it.

  31. RTB

    Is the consensus that the interim review by the DSMB is now moot? Seems that their 42 day period

  32. onestepahead

    Less than 3% of phase 3 covid drugs got a code listed. Look for yourselves. Some shorts trying to

    (3)
  33. mikeo

    they will use the M/M data and the NEWS2 results.

    (1)
  34. FBCoach18

    I will say this for fact. Executive orders aree a wish of this administration. They, Executive

    (2)
  35. fsoalex

    While I agree with you that the distribution of Leronlimab is muddled, I do not believe that the

    (7)
  36. nmbr1stckpckr

    I am very curious as to how the Company was able to "do what they did" to have money in the bank to

  37. Cassandra X

    The point of my post#67690 was to point out the danger I saw to all of the indications that

    (3)
  38. viridi

    Thanks Chuckles, I appreciate your analysis as it corresponds to my own. I think the difference

    (1)
  39. Riztheinvestor

    Well I cant say your wrong. Valid point.

  40. mtruong34

    We can't assume the FDA initiated the coding for leronlimab. Just because NP phrased it that way

  41. chazzledazzle

    Perfection is binary.

  42. Kharma

    ohm, I didn't assume they were randomly selecting new drugs to code. Didn't know how Leronlimab was

    (1)
  43. chuckles759

    I'm not sure that the $5B - $10B would be showing up in CytoDyn's checkbook balance. I ran some

  44. ohm20

    Probably most if not all phase 3 covid trial drugs . Got codes no Like I said

    (2)
  45. sean007

    How about a 65 ft trimaran...by Neely..

  46. sean007

    That was definitely a wink and a nod...they said Medicare/Medicaid.....he said FDA.....a veiled

    (1)
  47. sunclouds

    No need for DSMC review if trial if fully enrolled and drug fully administered and 28 day primary

    (3)
  48. chazzledazzle

    Correct. Not even my favorite Nader quote from today. (Paraphrased) 5-10 billion is the number

  49. ohm20

    I missed those posts but if they're like some of the spurious "doubts" you've posted in the past I

    (2)
  50. Riztheinvestor

    Thank you, makes sense when you put it so simply.

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Exploring the Future of the Virtual Tour Market by 2032

Updated Category News Views 210

Understanding the Virtual Tour Market Growth The virtual tour market has been experiencing an exponential growth trajectory, reaching a valuation of USD 8.89 billion in 2023. According to industry insights, this market is projected to achieve a remarkable USD 127.47 billion by 2032, reflecting a vigorous compound annual growth rate (CAGR) of 34.49% during the period from...

Continue Reading
Aqua Metals Prepares for Q2 2025 Results and Investor Call

Updated Category News Views 182

Aqua Metals Announces Upcoming Financial Results Aqua Metals, Inc. (NASDAQ: AQMS) is gearing up to share its financial results for the second quarter of 2025. This innovative company, recognized for its sustainable lithium-ion battery recycling, will release its results and provide a comprehensive business update on August 13, 2025. The announcement is eagerly anticipated...

Continue Reading
Christina Lake Cannabis Delays Annual Financial Statements Until July

Updated Category News Views 155

Christina Lake Cannabis Faces Delays in Financial Filings Christina Lake Cannabis Corp. (CSE: CLC) has recently announced a significant delay in the filing of its annual financial statements. The company indicated that it will be unable to submit these critical documents, which include management's discussion and analysis along with the required certifications from its...

Continue Reading
Choosing the Right Builder for Your Waterfront Oasis

Updated Category News Views 7

Why Building by the Water Calls for Expertise Diving headfirst into constructing a lakeside home feels a lot like trying to tame a wild stallion. On one hand, you've got that dream of a serene retreat; on the other, there are unique hurdles—waterfront regulations, environmental challenges, and the whims of Mother Nature. That's straight from Joe McGinley, VP of Lake...

Continue Reading
ASM International N.V. Updates Investors on Share Buyback Program

Updated Category News Views 165

ASM International N.V. Share Buyback Program Update ASM International N.V. reports no buyback transactions occurred during the week of June 30 to July 4, 2025. This marks an important pause in their ongoing efforts as they navigate dynamics in the semiconductor market. Company Overview ASM International N.V. is a noted player in the semiconductor industry, with its...

Continue Reading